| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10038074 | HBV | ENSG00000165646.14 | protein_coding | SLC18A2 | No | No | 6571 | Q05940 |
| TVIS10046857 | HBV | ENSG00000165646.14 | protein_coding | SLC18A2 | No | No | 6571 | Q05940 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | SLC18A2 |
|---|---|
| DrugBank ID | DB01454 |
| Drug Name | Midomafetamine |
| Target ID | BE0000118 |
| UniProt ID | Q05940 |
| Regulation Type | inhibitor |
| PubMed IDs | 20002520; 11861820 |
| Citations | Biezonski DK, Meyer JS: Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity. J Neurochem. 2010 Feb;112(4):951-62. doi: 10.1111/j.1471-4159.2009.06515.x. Epub 2009 Nov 30.@@Hansen JP, Riddle EL, Sandoval V, Brown JM, Gibb JW, Hanson GR, Fleckenstein AE: Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity. J Pharmacol Exp Ther. 2002 Mar;300(3):1093-100. |
| Groups | Experimental; Illicit; Investigational |
| Direct Classification | Benzodioxoles |
| SMILES | CNC(C)CC1=CC2=C(OCO2)C=C1 |
| Pathways | |
| PharmGKB | PA131887008 |
| ChEMBL | CHEMBL43048 |
